1. Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges

   • Sevan Dirmesropian
   • James G. Wood
   • Anthony T. Newall

   Current Opinion 25 February 2016 Pages: 723 - 731

   

2. Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions

   • Emma Frew

   Leading Article 11 March 2016 Pages: 733 - 740

3. Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective

   • P. Thokala
   • E. L. Simpson
   • P. Harrison

   Review Article 18 February 2016 Pages: 741 - 750

4. Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension

   • Shuyan Gu
   • Huimei Hu
   • Hengjin Dong

   Systematic Review 07 March 2016 Pages: 751 - 770

   

5. A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions

   • Catrin O. Plumpton
   • Daniel Roberts
   • Dyfrig A. Hughes

   Systematic Review 16 March 2016 Pages: 771 - 793

   

6. Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial

   • Lars Oddershede
   • Simon Walker
   • For the Protease Inhibitor monotherapy Versus Ongoing Triple therapy (PIVOT) Trial Team

   Original Research Article 10 March 2016 Pages: 795 - 804

7. The Impact of Different DCE-Based Approaches When Anchoring Utility Scores

   • Richard Norman
   • Brendan Mulhern
   • Rosalie Viney

   Original Research Article 31 March 2016 Pages: 805 - 814

   

8. Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

   • Jonathan Graham
   • Doreen McBride
   • Alan Brennan

   Original Research Article Open access 21 May 2016 Pages: 815 - 827